JP2003506358A - イソキノリン誘導体、該誘導体を含有する医薬組成物及び活性物質の製法 - Google Patents
イソキノリン誘導体、該誘導体を含有する医薬組成物及び活性物質の製法Info
- Publication number
- JP2003506358A JP2003506358A JP2001514304A JP2001514304A JP2003506358A JP 2003506358 A JP2003506358 A JP 2003506358A JP 2001514304 A JP2001514304 A JP 2001514304A JP 2001514304 A JP2001514304 A JP 2001514304A JP 2003506358 A JP2003506358 A JP 2003506358A
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- hydrogen atom
- formula
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 25
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 title abstract description 4
- 238000000034 method Methods 0.000 title description 106
- 239000013543 active substance Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 218
- 230000000949 anxiolytic effect Effects 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- -1 methylenedioxy Form Chemical group 0.000 claims description 178
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 156
- 229910052739 hydrogen Inorganic materials 0.000 claims description 110
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 56
- 239000002253 acid Substances 0.000 claims description 49
- 150000003839 salts Chemical class 0.000 claims description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 125000003545 alkoxy group Chemical group 0.000 claims description 46
- 239000000126 substance Substances 0.000 claims description 44
- 125000005843 halogen group Chemical group 0.000 claims description 39
- NKSZCPBUWGZONP-UHFFFAOYSA-N 3,4-dihydroisoquinoline Chemical class C1=CC=C2C=NCCC2=C1 NKSZCPBUWGZONP-UHFFFAOYSA-N 0.000 claims description 37
- 239000002585 base Substances 0.000 claims description 29
- 150000002537 isoquinolines Chemical class 0.000 claims description 25
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 25
- 150000007524 organic acids Chemical class 0.000 claims description 25
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 24
- 229910052801 chlorine Inorganic materials 0.000 claims description 23
- 150000007522 mineralic acids Chemical class 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 18
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 17
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical class C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 claims description 17
- 150000001408 amides Chemical class 0.000 claims description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 10
- PBYMYAJONQZORL-UHFFFAOYSA-N 1-methylisoquinoline Chemical compound C1=CC=C2C(C)=NC=CC2=C1 PBYMYAJONQZORL-UHFFFAOYSA-N 0.000 claims description 9
- 125000004429 atom Chemical group 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- IOEPOEDBBPRAEI-UHFFFAOYSA-N 1,2-dihydroisoquinoline Chemical class C1=CC=C2CNC=CC2=C1 IOEPOEDBBPRAEI-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
- 239000005977 Ethylene Substances 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 5
- 241000790917 Dioxys <bee> Species 0.000 claims description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical class C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 claims description 4
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 3
- 230000003197 catalytic effect Effects 0.000 claims description 2
- 238000006356 dehydrogenation reaction Methods 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
- VPKAHUMPZYVNIV-UHFFFAOYSA-N 1,4-dihydroisoquinoline Chemical class C1=CC=C2CC=NCC2=C1 VPKAHUMPZYVNIV-UHFFFAOYSA-N 0.000 claims 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 2
- JZZLDIIDMFCOGF-UHFFFAOYSA-N 1-methyl-3,4-dihydroisoquinoline Chemical compound C1=CC=C2C(C)=NCCC2=C1 JZZLDIIDMFCOGF-UHFFFAOYSA-N 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 claims 1
- 102100025036 Norrin Human genes 0.000 claims 1
- 101710085992 Norrin Proteins 0.000 claims 1
- 229940006460 bromide ion Drugs 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims 1
- 229940006461 iodide ion Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 210000003169 central nervous system Anatomy 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 154
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 141
- 238000005160 1H NMR spectroscopy Methods 0.000 description 120
- 239000000243 solution Substances 0.000 description 103
- 238000004458 analytical method Methods 0.000 description 99
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 96
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 96
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 80
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 72
- 239000011541 reaction mixture Substances 0.000 description 59
- 229910052757 nitrogen Inorganic materials 0.000 description 56
- 239000000203 mixture Substances 0.000 description 55
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 48
- 238000002844 melting Methods 0.000 description 47
- 230000008018 melting Effects 0.000 description 47
- 238000004364 calculation method Methods 0.000 description 45
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 34
- 239000012043 crude product Substances 0.000 description 33
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 33
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 31
- 239000013078 crystal Substances 0.000 description 31
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 238000003756 stirring Methods 0.000 description 26
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- 239000007787 solid Substances 0.000 description 24
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 239000000460 chlorine Substances 0.000 description 21
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 21
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 20
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 20
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 19
- 239000007858 starting material Substances 0.000 description 18
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 15
- 238000000354 decomposition reaction Methods 0.000 description 14
- 239000012074 organic phase Substances 0.000 description 14
- HEDRZPFGACZZDS-MICDWDOJSA-N deuterated chloroform Substances [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 9
- 235000011114 ammonium hydroxide Nutrition 0.000 description 9
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 9
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 8
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 8
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 238000012937 correction Methods 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 239000005457 ice water Substances 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 5
- OYJXTOVLKZDGFK-UHFFFAOYSA-N ethanol;2-propan-2-yloxypropane Chemical compound CCO.CC(C)OC(C)C OYJXTOVLKZDGFK-UHFFFAOYSA-N 0.000 description 5
- 230000006742 locomotor activity Effects 0.000 description 5
- 238000007363 ring formation reaction Methods 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
- RYOQVYHOVXOXIP-ZHACJKMWSA-N 1-[(e)-2-phenylethenyl]isoquinoline Chemical class N=1C=CC2=CC=CC=C2C=1\C=C\C1=CC=CC=C1 RYOQVYHOVXOXIP-ZHACJKMWSA-N 0.000 description 4
- CUCKVNLGZIYFNE-UHFFFAOYSA-N 5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound C1=CC(C(F)(F)F)=CC=C1C=CC(C1=C2)=NC=CC1=CC1=C2OCO1 CUCKVNLGZIYFNE-UHFFFAOYSA-N 0.000 description 4
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 150000001350 alkyl halides Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- APEJMQOBVMLION-UHFFFAOYSA-N cinnamamide Chemical compound NC(=O)C=CC1=CC=CC=C1 APEJMQOBVMLION-UHFFFAOYSA-N 0.000 description 4
- 239000002178 crystalline material Substances 0.000 description 4
- 229960003529 diazepam Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 4
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 3
- NKURAIZWEKKFAR-UHFFFAOYSA-N 3,3,3-trifluoro-2-methoxy-2-(3-methoxyphenyl)propan-1-amine Chemical compound COC1=CC=CC(C(CN)(OC)C(F)(F)F)=C1 NKURAIZWEKKFAR-UHFFFAOYSA-N 0.000 description 3
- HYRHTTXQOTWOLR-UHFFFAOYSA-N 3-[4-(trifluoromethyl)phenyl]propanamide Chemical compound NC(=O)CCC1=CC=C(C(F)(F)F)C=C1 HYRHTTXQOTWOLR-UHFFFAOYSA-N 0.000 description 3
- AKWXNNPSOHKGAT-UHFFFAOYSA-N 5-(2-phenylethyl)-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound N=1CCC2=CC=3OCOC=3C=C2C=1CCC1=CC=CC=C1 AKWXNNPSOHKGAT-UHFFFAOYSA-N 0.000 description 3
- NFERTQJCUBYZSS-UHFFFAOYSA-N Cl.Fc1ccc(C=CC2=NCCc3cc4OCOc4cc23)cc1 Chemical compound Cl.Fc1ccc(C=CC2=NCCc3cc4OCOc4cc23)cc1 NFERTQJCUBYZSS-UHFFFAOYSA-N 0.000 description 3
- 101100441092 Danio rerio crlf3 gene Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- XNZFFRJWTVYMBF-UHFFFAOYSA-N Hydrohydrastinine Natural products C1=C2CN(C)CCC2=CC2=C1OCO2 XNZFFRJWTVYMBF-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002249 anxiolytic agent Substances 0.000 description 3
- OUGIDAPQYNCXRA-UHFFFAOYSA-N beta-naphthoflavone Chemical compound O1C2=CC=C3C=CC=CC3=C2C(=O)C=C1C1=CC=CC=C1 OUGIDAPQYNCXRA-UHFFFAOYSA-N 0.000 description 3
- 150000003857 carboxamides Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940126543 compound 14 Drugs 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 150000002391 heterocyclic compounds Chemical class 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- FPKGTVXPIULTIP-UHFFFAOYSA-N n-ethyl-1,3-benzodioxol-5-amine Chemical compound CCNC1=CC=C2OCOC2=C1 FPKGTVXPIULTIP-UHFFFAOYSA-N 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 2
- ILBCVVKHECPITK-UHFFFAOYSA-N 1-[2-(4-fluorophenyl)ethenyl]-4,6-dimethoxy-4-(trifluoromethyl)-3h-isoquinoline Chemical compound N=1CC(OC)(C(F)(F)F)C2=CC(OC)=CC=C2C=1C=CC1=CC=C(F)C=C1 ILBCVVKHECPITK-UHFFFAOYSA-N 0.000 description 2
- NSKGEOZHYORJDO-UHFFFAOYSA-N 1-methyl-1,2-dihydroisoquinoline Chemical compound C1=CC=C2C(C)NC=CC2=C1 NSKGEOZHYORJDO-UHFFFAOYSA-N 0.000 description 2
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 2
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 description 2
- PLSWCMSPFHARPP-UHFFFAOYSA-N 3-(4-nitrophenyl)-n-[3,3,3-trifluoro-2-methoxy-2-(3-methoxyphenyl)propyl]prop-2-enamide Chemical compound COC1=CC=CC(C(CNC(=O)C=CC=2C=CC(=CC=2)[N+]([O-])=O)(OC)C(F)(F)F)=C1 PLSWCMSPFHARPP-UHFFFAOYSA-N 0.000 description 2
- VFQOFJQVKVEXIY-UHFFFAOYSA-N 3-(phenylmethoxycarbonylamino)-3-piperidin-3-ylpropanoic acid Chemical compound C1CCNCC1C(CC(=O)O)NC(=O)OCC1=CC=CC=C1 VFQOFJQVKVEXIY-UHFFFAOYSA-N 0.000 description 2
- RIYDEYWRFIHXBD-UHFFFAOYSA-N 3-[4-(trifluoromethyl)phenyl]prop-2-enoyl chloride Chemical compound FC(F)(F)C1=CC=C(C=CC(Cl)=O)C=C1 RIYDEYWRFIHXBD-UHFFFAOYSA-N 0.000 description 2
- OEIUMLSCWINLBB-UHFFFAOYSA-N 3-[4-(trifluoromethyl)phenyl]propanoic acid Chemical compound OC(=O)CCC1=CC=C(C(F)(F)F)C=C1 OEIUMLSCWINLBB-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- IOHOTIGNNIPUCP-UHFFFAOYSA-N 3-phenyl-n-[3,3,3-trifluoro-2-methoxy-2-(3-methoxyphenyl)propyl]prop-2-enamide Chemical compound COC1=CC=CC(C(CNC(=O)C=CC=2C=CC=CC=2)(OC)C(F)(F)F)=C1 IOHOTIGNNIPUCP-UHFFFAOYSA-N 0.000 description 2
- SUVHQJYRSITWJY-UHFFFAOYSA-N 4,6-dimethoxy-1-(2-phenylethenyl)-4-(trifluoromethyl)-3h-isoquinolin-2-ium;chloride Chemical compound [Cl-].[NH+]=1CC(OC)(C(F)(F)F)C2=CC(OC)=CC=C2C=1C=CC1=CC=CC=C1 SUVHQJYRSITWJY-UHFFFAOYSA-N 0.000 description 2
- FOUJQQNBKGJULP-UHFFFAOYSA-N 4,6-dimethoxy-1-methyl-4-(trifluoromethyl)-3h-isoquinoline Chemical compound CC1=NCC(OC)(C(F)(F)F)C2=CC(OC)=CC=C21 FOUJQQNBKGJULP-UHFFFAOYSA-N 0.000 description 2
- BEOBZEOPTQQELP-UHFFFAOYSA-N 4-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC=C(C=O)C=C1 BEOBZEOPTQQELP-UHFFFAOYSA-N 0.000 description 2
- NTPLXRHDUXRPNE-UHFFFAOYSA-N 4-methoxyacetophenone Chemical compound COC1=CC=C(C(C)=O)C=C1 NTPLXRHDUXRPNE-UHFFFAOYSA-N 0.000 description 2
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 2
- NSLJVQUDZCZJLK-UHFFFAOYSA-N 6,7-dimethoxy-3,4-dihydroisoquinoline Chemical compound C1CN=CC2=C1C=C(OC)C(OC)=C2 NSLJVQUDZCZJLK-UHFFFAOYSA-N 0.000 description 2
- AUMDIWYWMIMMEX-UHFFFAOYSA-N 6-methyl-2,3-dihydro-[1,4]dioxino[2,3-g]isoquinoline Chemical compound O1CCOC2=C1C=C1C=CN=C(C)C1=C2 AUMDIWYWMIMMEX-UHFFFAOYSA-N 0.000 description 2
- SCTLILQDZHESKV-UHFFFAOYSA-N 6-methyl-5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-7,8-dihydro-5h-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound CN1CCC2=CC=3OCOC=3C=C2C1C=CC1=CC=C(C(F)(F)F)C=C1 SCTLILQDZHESKV-UHFFFAOYSA-N 0.000 description 2
- QYUVYAOHKSVPCI-UHFFFAOYSA-M 6-methyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinolin-6-ium;iodide Chemical compound [I-].C1=C2CC[N+](C)=CC2=CC2=C1OCO2 QYUVYAOHKSVPCI-UHFFFAOYSA-M 0.000 description 2
- WCGQURWLOZOJBN-UHFFFAOYSA-N 9-propyl-6-[2-[4-(trifluoromethyl)phenyl]ethenyl]-2,3-dihydro-[1,4]dioxino[2,3-g]isoquinolin-7-ium;chloride Chemical compound [Cl-].C12=CC=3OCCOC=3C=C2C(CCC)=C[NH+]=C1C=CC1=CC=C(C(F)(F)F)C=C1 WCGQURWLOZOJBN-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910020323 ClF3 Inorganic materials 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- OTNODDXCYZPVBM-UHFFFAOYSA-N N-ethyl-1,3-benzodioxol-5-amine hypochlorous acid Chemical compound ClO.C1OC=2C=C(C=CC2O1)NCC OTNODDXCYZPVBM-UHFFFAOYSA-N 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GQXXXWYJEJMHHZ-UHFFFAOYSA-N [Cl-].COc1ccc2c(C=Cc3ccccc3)[nH+]cc(c2c1)C(F)(F)F Chemical compound [Cl-].COc1ccc2c(C=Cc3ccccc3)[nH+]cc(c2c1)C(F)(F)F GQXXXWYJEJMHHZ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- OHMBHFSEKCCCBW-UHFFFAOYSA-N hexane-2,5-diol Chemical compound CC(O)CCC(C)O OHMBHFSEKCCCBW-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 150000002688 maleic acid derivatives Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- PBYAELPLXVWBKW-UHFFFAOYSA-N n-[3,3,3-trifluoro-2-methoxy-2-(3-methoxyphenyl)propyl]acetamide Chemical compound COC1=CC=CC(C(CNC(C)=O)(OC)C(F)(F)F)=C1 PBYAELPLXVWBKW-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- XTUSEBKMEQERQV-UHFFFAOYSA-N propan-2-ol;hydrate Chemical compound O.CC(C)O XTUSEBKMEQERQV-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 125000005504 styryl group Chemical group 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- ANRMAUMHJREENI-ZZXKWVIFSA-N (E)-4-(trifluoromethyl)cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=C(C(F)(F)F)C=C1 ANRMAUMHJREENI-ZZXKWVIFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- IRFSXVIRXMYULF-UHFFFAOYSA-N 1,2-dihydroquinoline Chemical compound C1=CC=C2C=CCNC2=C1 IRFSXVIRXMYULF-UHFFFAOYSA-N 0.000 description 1
- WXZZPQGBYUECAZ-UHFFFAOYSA-N 1,4-dihydroisoquinoline;hydrochloride Chemical compound Cl.C1=CC=C2CC=NCC2=C1 WXZZPQGBYUECAZ-UHFFFAOYSA-N 0.000 description 1
- RYOQVYHOVXOXIP-UHFFFAOYSA-N 1-(2-phenylethenyl)isoquinoline Chemical class N=1C=CC2=CC=CC=C2C=1C=CC1=CC=CC=C1 RYOQVYHOVXOXIP-UHFFFAOYSA-N 0.000 description 1
- VRALBRYBOMBKNI-UHFFFAOYSA-N 1-[2-(4-fluorophenyl)ethenyl]-6-methoxy-4-(trifluoromethyl)isoquinoline Chemical compound N=1C=C(C(F)(F)F)C2=CC(OC)=CC=C2C=1C=CC1=CC=C(F)C=C1 VRALBRYBOMBKNI-UHFFFAOYSA-N 0.000 description 1
- WUOMWEKLAUGNEN-UHFFFAOYSA-N 1-[2-[4-(trifluoromethyl)phenyl]ethenyl]-3,4-dihydroisoquinoline Chemical compound C1=CC(C(F)(F)F)=CC=C1C=CC1=NCCC2=CC=CC=C12 WUOMWEKLAUGNEN-UHFFFAOYSA-N 0.000 description 1
- PLDWAJLZAAHOGG-UHFFFAOYSA-N 1-bromo-3-methoxybenzene Chemical compound COC1=CC=CC(Br)=C1 PLDWAJLZAAHOGG-UHFFFAOYSA-N 0.000 description 1
- YSUSKYKCCIRXBN-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-3,3,3-trifluoro-2-methoxypropan-1-amine Chemical compound COC(CN)(C(F)(F)F)C1=CC=C2OCOC2=C1 YSUSKYKCCIRXBN-UHFFFAOYSA-N 0.000 description 1
- GROJYOFFHRLXDW-UHFFFAOYSA-N 2-(2,3-dihydro-1,4-benzodioxin-6-yl)pentan-1-amine Chemical compound O1CCOC2=CC(C(CN)CCC)=CC=C21 GROJYOFFHRLXDW-UHFFFAOYSA-N 0.000 description 1
- IHCLZIIKZFCPJD-UHFFFAOYSA-N 2-(3-methoxyphenyl)propanenitrile Chemical compound COC1=CC=CC(C(C)C#N)=C1 IHCLZIIKZFCPJD-UHFFFAOYSA-N 0.000 description 1
- LIUNIQLWIXSNHF-UHFFFAOYSA-N 3,3,3-trifluoro-2-(3-methoxyphenyl)propan-1-amine Chemical compound COC1=CC=CC(C(CN)C(F)(F)F)=C1 LIUNIQLWIXSNHF-UHFFFAOYSA-N 0.000 description 1
- NATJVFWMMDLUER-UHFFFAOYSA-N 3,3,3-trifluoro-2-methoxy-2-(3-methoxyphenyl)propanenitrile Chemical compound COC1=CC=CC(C(OC)(C#N)C(F)(F)F)=C1 NATJVFWMMDLUER-UHFFFAOYSA-N 0.000 description 1
- GDTSJMKGXGJFGQ-UHFFFAOYSA-N 3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound O1B([O-])OB2OB([O-])OB1O2 GDTSJMKGXGJFGQ-UHFFFAOYSA-N 0.000 description 1
- AUZPXZMJNZVMND-UHFFFAOYSA-N 3-(4-fluorophenyl)-n-[3,3,3-trifluoro-2-methoxy-2-(3-methoxyphenyl)propyl]prop-2-enamide Chemical compound COC1=CC=CC(C(CNC(=O)C=CC=2C=CC(F)=CC=2)(OC)C(F)(F)F)=C1 AUZPXZMJNZVMND-UHFFFAOYSA-N 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- JEMHEZHOFGZMMI-UHFFFAOYSA-N 4,6-dimethoxy-4-(trifluoromethyl)-1-[2-[4-(trifluoromethyl)phenyl]ethenyl]-3h-isoquinoline Chemical compound N=1CC(OC)(C(F)(F)F)C2=CC(OC)=CC=C2C=1C=CC1=CC=C(C(F)(F)F)C=C1 JEMHEZHOFGZMMI-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KLWDPIXDUVYHMS-UHFFFAOYSA-N 4-chloro-n-ethylaniline Chemical compound CCNC1=CC=C(Cl)C=C1 KLWDPIXDUVYHMS-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- CELRAHVPTZYSAJ-UHFFFAOYSA-N 5,6-dimethyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound C1=C2C(C)N(C)CCC2=CC2=C1OCO2 CELRAHVPTZYSAJ-UHFFFAOYSA-N 0.000 description 1
- YXWOZHZOWCVLDK-UHFFFAOYSA-N 5-[2-(3,4-dimethoxyphenyl)ethenyl]-8-hexyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCCCCCC1CN=C(C=Cc2ccc(OC)c(OC)c2)c2cc3OCOc3cc12 YXWOZHZOWCVLDK-UHFFFAOYSA-N 0.000 description 1
- VCTAZAVISDSFFQ-UHFFFAOYSA-N 5-[2-(3,4-dimethoxyphenyl)ethenyl]-8-propyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCCC1CN=C(C=Cc2ccc(OC)c(OC)c2)c2cc3OCOc3cc12 VCTAZAVISDSFFQ-UHFFFAOYSA-N 0.000 description 1
- UQIONFUYDDFQAO-UHFFFAOYSA-N 5-[2-(4-fluorophenyl)ethenyl]-6-methyl-5h-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound CN1C=CC2=CC=3OCOC=3C=C2C1C=CC1=CC=C(F)C=C1 UQIONFUYDDFQAO-UHFFFAOYSA-N 0.000 description 1
- HQGJKLOWDFLBLD-UHFFFAOYSA-M 5-[2-(4-fluorophenyl)ethenyl]-6-methyl-[1,3]dioxolo[4,5-g]isoquinolin-6-ium;iodide Chemical compound [I-].C[N+]1=CC=C2C=C3OCOC3=CC2=C1C=CC1=CC=C(F)C=C1 HQGJKLOWDFLBLD-UHFFFAOYSA-M 0.000 description 1
- ZFPCFEXZVHRTKW-UHFFFAOYSA-N 5-[2-(4-fluorophenyl)ethenyl]-8-hexyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCCCCCC1CN=C(C=Cc2ccc(F)cc2)c2cc3OCOc3cc12 ZFPCFEXZVHRTKW-UHFFFAOYSA-N 0.000 description 1
- VIPLNPOUEKUUSS-UHFFFAOYSA-N 5-[2-(4-fluorophenyl)ethenyl]-8-methyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CC1CN=C(C=Cc2ccc(F)cc2)c2cc3OCOc3cc12 VIPLNPOUEKUUSS-UHFFFAOYSA-N 0.000 description 1
- HLSYMFUBURMTEQ-UHFFFAOYSA-N 5-[2-(4-fluorophenyl)ethenyl]-8-propyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCCC1CN=C(C=Cc2ccc(F)cc2)c2cc3OCOc3cc12 HLSYMFUBURMTEQ-UHFFFAOYSA-N 0.000 description 1
- MAVNOBMJFQOOQA-UHFFFAOYSA-N 5-[2-(4-methoxyphenyl)ethenyl]-8-propyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCCC1CN=C(C=Cc2ccc(OC)cc2)c2cc3OCOc3cc12 MAVNOBMJFQOOQA-UHFFFAOYSA-N 0.000 description 1
- YMLMAKPCTCESIS-UHFFFAOYSA-N 5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound C1=CC(C(F)(F)F)=CC=C1C=CC1C2=CC(OCO3)=C3C=C2CCN1 YMLMAKPCTCESIS-UHFFFAOYSA-N 0.000 description 1
- UWUQQPIUBYCYGI-UHFFFAOYSA-N 5-methyl-8-(trifluoromethyl)-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound C1=C2C(C)=NC=C(C(F)(F)F)C2=CC2=C1OCO2 UWUQQPIUBYCYGI-UHFFFAOYSA-N 0.000 description 1
- SKIFFHLEGPVJBZ-UHFFFAOYSA-N 6,7-dihydro-[1,3]dioxolo[4,5-h]isoquinoline Chemical compound C1CN=CC2=C(OCO3)C3=CC=C21 SKIFFHLEGPVJBZ-UHFFFAOYSA-N 0.000 description 1
- KZCWEOPDFRCBPU-UHFFFAOYSA-N 6-[2-[4-(trifluoromethyl)phenyl]ethenyl]-2,3-dihydro-[1,4]dioxino[2,3-g]isoquinoline Chemical compound C1=CC(C(F)(F)F)=CC=C1C=CC(C1=C2)=NC=CC1=CC1=C2OCCO1 KZCWEOPDFRCBPU-UHFFFAOYSA-N 0.000 description 1
- VDFFWSZHYQBACH-UHFFFAOYSA-N 6-methoxy-1-(2-phenylethenyl)-4-(trifluoromethyl)isoquinoline Chemical compound N=1C=C(C(F)(F)F)C2=CC(OC)=CC=C2C=1C=CC1=CC=CC=C1 VDFFWSZHYQBACH-UHFFFAOYSA-N 0.000 description 1
- WAIZHIPGFSCKIP-UHFFFAOYSA-N 6-methoxy-1-[2-(4-nitrophenyl)ethenyl]-4-(trifluoromethyl)isoquinolin-2-ium;chloride Chemical compound [Cl-].[NH+]=1C=C(C(F)(F)F)C2=CC(OC)=CC=C2C=1C=CC1=CC=C([N+]([O-])=O)C=C1 WAIZHIPGFSCKIP-UHFFFAOYSA-N 0.000 description 1
- SRDHDRGNHBWYGN-UHFFFAOYSA-N 6-methoxy-1-[2-(4-nitrophenyl)ethenyl]-4-(trifluoromethyl)isoquinoline Chemical compound N=1C=C(C(F)(F)F)C2=CC(OC)=CC=C2C=1C=CC1=CC=C([N+]([O-])=O)C=C1 SRDHDRGNHBWYGN-UHFFFAOYSA-N 0.000 description 1
- HQVGKHPZGGGJIS-UHFFFAOYSA-N 6-methoxy-1-methyl-4-(trifluoromethyl)isoquinoline Chemical compound CC1=NC=C(C(F)(F)F)C2=CC(OC)=CC=C21 HQVGKHPZGGGJIS-UHFFFAOYSA-N 0.000 description 1
- VIBLKGVPLPSVFW-UHFFFAOYSA-N 6-methoxy-4-(trifluoromethyl)-1-[2-[4-(trifluoromethyl)phenyl]ethenyl]isoquinoline Chemical compound N=1C=C(C(F)(F)F)C2=CC(OC)=CC=C2C=1C=CC1=CC=C(C(F)(F)F)C=C1 VIBLKGVPLPSVFW-UHFFFAOYSA-N 0.000 description 1
- VVTDRPAONFOQAE-UHFFFAOYSA-N 6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-6-ium;chloride Chemical compound [Cl-].C1=C2C[NH+](C)CCC2=CC2=C1OCO2 VVTDRPAONFOQAE-UHFFFAOYSA-N 0.000 description 1
- JMUYRJIFXUPRCU-UHFFFAOYSA-N 6-methyl-5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-5h-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound CN1C=CC2=CC=3OCOC=3C=C2C1C=CC1=CC=C(C(F)(F)F)C=C1 JMUYRJIFXUPRCU-UHFFFAOYSA-N 0.000 description 1
- AFNLDTDCCHMFDL-UHFFFAOYSA-M 6-methyl-5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-[1,3]dioxolo[4,5-g]isoquinolin-6-ium;iodide Chemical compound [I-].C[N+]1=CC=C2C=C3OCOC3=CC2=C1C=CC1=CC=C(C(F)(F)F)C=C1 AFNLDTDCCHMFDL-UHFFFAOYSA-M 0.000 description 1
- BAKKYYKTHHIZOE-UHFFFAOYSA-M 6-methyl-[1,3]dioxolo[4,5-g]isoquinolin-6-ium;iodide Chemical compound [I-].C1=C2OCOC2=CC2=C[N+](C)=CC=C21 BAKKYYKTHHIZOE-UHFFFAOYSA-M 0.000 description 1
- CRCWUBLTFGOMDD-UHFFFAOYSA-N 7-ethoxyresorufin Chemical compound C1=CC(=O)C=C2OC3=CC(OCC)=CC=C3N=C21 CRCWUBLTFGOMDD-UHFFFAOYSA-N 0.000 description 1
- KLYXTDNNPSOMOG-UHFFFAOYSA-N 8-(trifluoromethyl)-5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound C1=CC(C(F)(F)F)=CC=C1C=CC(C1=C2)=NC=C(C(F)(F)F)C1=CC1=C2OCO1 KLYXTDNNPSOMOG-UHFFFAOYSA-N 0.000 description 1
- BZDKXHUZAAPJJC-UHFFFAOYSA-N 8-butyl-5-[2-(4-fluorophenyl)ethenyl]-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCCCC1CN=C(C=Cc2ccc(F)cc2)c2cc3OCOc3cc12 BZDKXHUZAAPJJC-UHFFFAOYSA-N 0.000 description 1
- ZBQGMEVFTNWAKP-UHFFFAOYSA-N 8-butyl-5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCCCC1CN=C(C=Cc2ccc(cc2)C(F)(F)F)c2cc3OCOc3cc12 ZBQGMEVFTNWAKP-UHFFFAOYSA-N 0.000 description 1
- ZEFBCIABYUUFIR-UHFFFAOYSA-N 8-ethyl-5-[2-(4-methoxyphenyl)ethenyl]-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCC1CN=C(C=Cc2ccc(OC)cc2)c2cc3OCOc3cc12 ZEFBCIABYUUFIR-UHFFFAOYSA-N 0.000 description 1
- MBEDRVFQIYKROL-UHFFFAOYSA-N 8-ethyl-5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCC1CN=C(C=Cc2ccc(cc2)C(F)(F)F)c2cc3OCOc3cc12 MBEDRVFQIYKROL-UHFFFAOYSA-N 0.000 description 1
- MDOAUCZFXGQSMT-UHFFFAOYSA-N 8-hexyl-5-[2-(4-methoxyphenyl)ethenyl]-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCCCCCC1CN=C(C=Cc2ccc(OC)cc2)c2cc3OCOc3cc12 MDOAUCZFXGQSMT-UHFFFAOYSA-N 0.000 description 1
- FYANGPPLZPBXPW-UHFFFAOYSA-N 8-methoxy-5-methyl-8-(trifluoromethyl)-7H-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound CC1=NCC(C2=CC3=C(C=C12)OCO3)(C(F)(F)F)OC FYANGPPLZPBXPW-UHFFFAOYSA-N 0.000 description 1
- UNHJTVDCOFZUEH-UHFFFAOYSA-N 8-methoxy-8-(trifluoromethyl)-5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-7h-[1,3]dioxolo[4,5-g]isoquinoline Chemical compound C12=CC=3OCOC=3C=C2C(OC)(C(F)(F)F)CN=C1C=CC1=CC=C(C(F)(F)F)C=C1 UNHJTVDCOFZUEH-UHFFFAOYSA-N 0.000 description 1
- ZKVXOVZQJWEUQZ-UHFFFAOYSA-N 8-propyl-5-[2-[4-(trifluoromethyl)phenyl]ethenyl]-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline hydrochloride Chemical compound Cl.CCCC1CN=C(C=Cc2ccc(cc2)C(F)(F)F)c2cc3OCOc3cc12 ZKVXOVZQJWEUQZ-UHFFFAOYSA-N 0.000 description 1
- YDTXNISHJZQTGL-UHFFFAOYSA-N 9-propyl-6-[2-[4-(trifluoromethyl)phenyl]ethenyl]-2,3-dihydro-[1,4]dioxino[2,3-g]isoquinoline Chemical compound C12=CC=3OCCOC=3C=C2C(CCC)=CN=C1C=CC1=CC=C(C(F)(F)F)C=C1 YDTXNISHJZQTGL-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- KPTYSRVWIUCKIF-UHFFFAOYSA-N C(#N)C1=CC=C(C=CC2N(C=CC3=CC(=C(C(=C23)OC)OC)OC)C)C=C1 Chemical compound C(#N)C1=CC=C(C=CC2N(C=CC3=CC(=C(C(=C23)OC)OC)OC)C)C=C1 KPTYSRVWIUCKIF-UHFFFAOYSA-N 0.000 description 1
- NGKJWNVYPVTDOW-UHFFFAOYSA-N C(=O)(C(=O)O)CC(=O)OC(CC(=O)C(=O)O)=O Chemical compound C(=O)(C(=O)O)CC(=O)OC(CC(=O)C(=O)O)=O NGKJWNVYPVTDOW-UHFFFAOYSA-N 0.000 description 1
- SGNAILPZTGZQJR-UHFFFAOYSA-N CCCC1=CN=C(C2=CC3=C(C=C21)OCO3)C=CC4=CC=C(C=C4)C(F)(F)F Chemical compound CCCC1=CN=C(C2=CC3=C(C=C21)OCO3)C=CC4=CC=C(C=C4)C(F)(F)F SGNAILPZTGZQJR-UHFFFAOYSA-N 0.000 description 1
- HAWVKSFIJSDRCL-UHFFFAOYSA-N COC1=CC2=C(C=C1)C(=[NH+]CC2(C(F)(F)F)OC)C=CC3=CC=C(C=C3)F.[Cl-] Chemical compound COC1=CC2=C(C=C1)C(=[NH+]CC2(C(F)(F)F)OC)C=CC3=CC=C(C=C3)F.[Cl-] HAWVKSFIJSDRCL-UHFFFAOYSA-N 0.000 description 1
- QVPGOOCFWRIVHB-UHFFFAOYSA-N COC=1C=C(C=CC2=NC=CC3=CC4=C(C=C23)OCCO4)C=CC1OC Chemical compound COC=1C=C(C=CC2=NC=CC3=CC4=C(C=C23)OCCO4)C=CC1OC QVPGOOCFWRIVHB-UHFFFAOYSA-N 0.000 description 1
- VVKDSOXDUZXRNX-UHFFFAOYSA-M C[N+]1=C(C2=C(C(=C(C=C2C=C1)OC)OC)OC)C=CC3=CC=C(C=C3)C#N.[I-] Chemical compound C[N+]1=C(C2=C(C(=C(C=C2C=C1)OC)OC)OC)C=CC3=CC=C(C=C3)C#N.[I-] VVKDSOXDUZXRNX-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 244000248349 Citrus limon Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- CCPQEZVXJPSAFZ-UHFFFAOYSA-N Cl.CC1CN=C(C2=CC3=C(C=C12)OCO3)C=CC3=CC=C(C=C3)C(F)(F)F Chemical compound Cl.CC1CN=C(C2=CC3=C(C=C12)OCO3)C=CC3=CC=C(C=C3)C(F)(F)F CCPQEZVXJPSAFZ-UHFFFAOYSA-N 0.000 description 1
- GFYFQCQJDMTVDY-UHFFFAOYSA-N Cl.CC1CN=C(C2=CC3=C(C=C12)OCO3)C=CC3=CC=C(C=C3)OC Chemical compound Cl.CC1CN=C(C2=CC3=C(C=C12)OCO3)C=CC3=CC=C(C=C3)OC GFYFQCQJDMTVDY-UHFFFAOYSA-N 0.000 description 1
- DWVMBTGLZRUOKR-UHFFFAOYSA-N Cl.CCC1CN=C(C=Cc2ccc(OC)c(OC)c2)c2cc3OCOc3cc12 Chemical compound Cl.CCC1CN=C(C=Cc2ccc(OC)c(OC)c2)c2cc3OCOc3cc12 DWVMBTGLZRUOKR-UHFFFAOYSA-N 0.000 description 1
- BXURPFFGWGVVPZ-UHFFFAOYSA-N Cl.CCCCC1CN=C(C=Cc2ccc(OC)c(OC)c2)c2cc3OCOc3cc12 Chemical compound Cl.CCCCC1CN=C(C=Cc2ccc(OC)c(OC)c2)c2cc3OCOc3cc12 BXURPFFGWGVVPZ-UHFFFAOYSA-N 0.000 description 1
- PITGVAUCVJFZCS-UHFFFAOYSA-N Cl.CCCCC1CN=C(C=Cc2ccc(OC)cc2)c2cc3OCOc3cc12 Chemical compound Cl.CCCCC1CN=C(C=Cc2ccc(OC)cc2)c2cc3OCOc3cc12 PITGVAUCVJFZCS-UHFFFAOYSA-N 0.000 description 1
- GMGSQQKJEMFZPQ-UHFFFAOYSA-N Cl.CCCCCCC1CN=C(C=Cc2ccc(cc2)C(F)(F)F)c2cc3OCOc3cc12 Chemical compound Cl.CCCCCCC1CN=C(C=Cc2ccc(cc2)C(F)(F)F)c2cc3OCOc3cc12 GMGSQQKJEMFZPQ-UHFFFAOYSA-N 0.000 description 1
- FXPFYTDNVGKHMU-UHFFFAOYSA-N Cl.COc1ccc(C=CC2=NCC(C)c3cc4OCOc4cc23)cc1OC Chemical compound Cl.COc1ccc(C=CC2=NCC(C)c3cc4OCOc4cc23)cc1OC FXPFYTDNVGKHMU-UHFFFAOYSA-N 0.000 description 1
- PKEUFEZLVGBOSD-UHFFFAOYSA-N Cl.FC(F)(F)c1ccc(C=CC2=NCCc3cc4OCOc4cc23)cc1 Chemical compound Cl.FC(F)(F)c1ccc(C=CC2=NCCc3cc4OCOc4cc23)cc1 PKEUFEZLVGBOSD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ROWVIYMWVZAUCN-UHFFFAOYSA-N FC(C(C#N)(C1=CC2=C(C=C1)OCO2)OC)(F)F Chemical compound FC(C(C#N)(C1=CC2=C(C=C1)OCO2)OC)(F)F ROWVIYMWVZAUCN-UHFFFAOYSA-N 0.000 description 1
- CIKLOZPRQJWURM-UHFFFAOYSA-N FC(C1=CC=C(C=C1)CCC1=NCCC2=CC=C(C=C12)Cl)(F)F Chemical compound FC(C1=CC=C(C=C1)CCC1=NCCC2=CC=C(C=C12)Cl)(F)F CIKLOZPRQJWURM-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 238000011785 NMRI mouse Methods 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- STSCVKRWJPWALQ-UHFFFAOYSA-N TRIFLUOROACETIC ACID ETHYL ESTER Chemical compound CCOC(=O)C(F)(F)F STSCVKRWJPWALQ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- ZKZGXLGGNHJXOQ-UHFFFAOYSA-M [Br-].C[N+]1=C(C=Cc2ccc(F)cc2)c2cc3OCOc3cc2CC1 Chemical compound [Br-].C[N+]1=C(C=Cc2ccc(F)cc2)c2cc3OCOc3cc2CC1 ZKZGXLGGNHJXOQ-UHFFFAOYSA-M 0.000 description 1
- PTXKLTMZORBTGD-UHFFFAOYSA-M [Br-].C[N+]1=C(C=Cc2ccc(cc2)C(F)(F)F)c2cc3OCOc3cc2CC1 Chemical compound [Br-].C[N+]1=C(C=Cc2ccc(cc2)C(F)(F)F)c2cc3OCOc3cc2CC1 PTXKLTMZORBTGD-UHFFFAOYSA-M 0.000 description 1
- QVOAYQFCFXNVPS-UHFFFAOYSA-N [Cl-].COC1(C[NH+]=C(C2=CC=C(C=C12)OC)C=CC1=CC=C(C=C1)C(F)(F)F)C(F)(F)F Chemical compound [Cl-].COC1(C[NH+]=C(C2=CC=C(C=C12)OC)C=CC1=CC=C(C=C1)C(F)(F)F)C(F)(F)F QVOAYQFCFXNVPS-UHFFFAOYSA-N 0.000 description 1
- GRZNRNBKNLYEMB-UHFFFAOYSA-N [Cl-].COC1(C[NH+]=C(C=Cc2ccc(cc2)C(F)(F)F)c2cc3OCOc3cc12)C(F)(F)F Chemical compound [Cl-].COC1(C[NH+]=C(C=Cc2ccc(cc2)C(F)(F)F)c2cc3OCOc3cc12)C(F)(F)F GRZNRNBKNLYEMB-UHFFFAOYSA-N 0.000 description 1
- JELJCOUXVCOPEK-UHFFFAOYSA-N [Cl-].COc1ccc2c(C=Cc3ccc(cc3)C(F)(F)F)[nH+]cc(c2c1)C(F)(F)F Chemical compound [Cl-].COc1ccc2c(C=Cc3ccc(cc3)C(F)(F)F)[nH+]cc(c2c1)C(F)(F)F JELJCOUXVCOPEK-UHFFFAOYSA-N 0.000 description 1
- BSNPCVYIVFIYHE-UHFFFAOYSA-M [I-].C1(=CC=CC=C1)CCC1=[N+](CCC2=CC3=C(C=C12)OCO3)C Chemical compound [I-].C1(=CC=CC=C1)CCC1=[N+](CCC2=CC3=C(C=C12)OCO3)C BSNPCVYIVFIYHE-UHFFFAOYSA-M 0.000 description 1
- XNNNBRCIJFTPKE-UHFFFAOYSA-M [I-].CC[n+]1ccc2cc3OCOc3cc2c1C=Cc1ccc(cc1)C(F)(F)F Chemical compound [I-].CC[n+]1ccc2cc3OCOc3cc2c1C=Cc1ccc(cc1)C(F)(F)F XNNNBRCIJFTPKE-UHFFFAOYSA-M 0.000 description 1
- IYNYRPOYVSYZFP-UHFFFAOYSA-M [I-].C[N+]1(C)CCc2cc3OCOc3cc2C1C=Cc1ccc(cc1)C(F)(F)F Chemical compound [I-].C[N+]1(C)CCc2cc3OCOc3cc2C1C=Cc1ccc(cc1)C(F)(F)F IYNYRPOYVSYZFP-UHFFFAOYSA-M 0.000 description 1
- KDDDFCVDLFZAJV-KSBRXOFISA-N [O-]C(=O)\C=C/C([O-])=O.[NH+]=1CC(OC)(C(F)(F)F)c2cc(OC)ccc2C=1C=Cc1ccc(F)cc1.[NH+]=1CC(OC)(C(F)(F)F)c2cc(OC)ccc2C=1C=Cc1ccc(F)cc1 Chemical compound [O-]C(=O)\C=C/C([O-])=O.[NH+]=1CC(OC)(C(F)(F)F)c2cc(OC)ccc2C=1C=Cc1ccc(F)cc1.[NH+]=1CC(OC)(C(F)(F)F)c2cc(OC)ccc2C=1C=Cc1ccc(F)cc1 KDDDFCVDLFZAJV-KSBRXOFISA-N 0.000 description 1
- XPRDROUOOJDJII-KSBRXOFISA-N [O-]C(=O)\C=C/C([O-])=O.[NH+]=1CC(OC)(C(F)(F)F)c2cc(OC)ccc2C=1C=Cc1ccccc1.[NH+]=1CC(OC)(C(F)(F)F)c2cc(OC)ccc2C=1C=Cc1ccccc1 Chemical compound [O-]C(=O)\C=C/C([O-])=O.[NH+]=1CC(OC)(C(F)(F)F)c2cc(OC)ccc2C=1C=Cc1ccccc1.[NH+]=1CC(OC)(C(F)(F)F)c2cc(OC)ccc2C=1C=Cc1ccccc1 XPRDROUOOJDJII-KSBRXOFISA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- JAJVYESKUNMYPN-UHFFFAOYSA-N backebergine Chemical class C1=NC=C2C=C(OC)C(OC)=CC2=C1 JAJVYESKUNMYPN-UHFFFAOYSA-N 0.000 description 1
- 238000009227 behaviour therapy Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 150000001649 bromium compounds Chemical group 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- GFHNAMRJFCEERV-UHFFFAOYSA-L cobalt chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Co+2] GFHNAMRJFCEERV-UHFFFAOYSA-L 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 101150055214 cyp1a1 gene Proteins 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- IYRMNDOLPONSCJ-UHFFFAOYSA-N isoquinolin-2-ium;chloride Chemical compound Cl.C1=NC=CC2=CC=CC=C21 IYRMNDOLPONSCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- FKUUDDGRDRPAQQ-UHFFFAOYSA-M magnesium;methoxybenzene;bromide Chemical compound [Mg+2].[Br-].COC1=CC=C[C-]=C1 FKUUDDGRDRPAQQ-UHFFFAOYSA-M 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- GVWJLWRSELWQEI-UHFFFAOYSA-N n-[2-(1,3-benzodioxol-5-yl)-3,3,3-trifluoro-2-methoxypropyl]acetamide Chemical compound CC(=O)NCC(OC)(C(F)(F)F)C1=CC=C2OCOC2=C1 GVWJLWRSELWQEI-UHFFFAOYSA-N 0.000 description 1
- IDEGNRPKPVIBAU-UHFFFAOYSA-N n-[3,3,3-trifluoro-2-methoxy-2-(3-methoxyphenyl)propyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide Chemical compound COC1=CC=CC(C(CNC(=O)C=CC=2C=CC(=CC=2)C(F)(F)F)(OC)C(F)(F)F)=C1 IDEGNRPKPVIBAU-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- FQSCDFSPZNJRFL-UHFFFAOYSA-N n-ethyl-2,3-dihydro-1,4-benzodioxin-6-amine Chemical compound O1CCOC2=CC(NCC)=CC=C21 FQSCDFSPZNJRFL-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 description 1
- CMJCEVKJYRZMIA-UHFFFAOYSA-M thallium(i) iodide Chemical compound [Tl]I CMJCEVKJYRZMIA-UHFFFAOYSA-M 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- APEJMQOBVMLION-VOTSOKGWSA-N trans-cinnamamide Chemical compound NC(=O)\C=C\C1=CC=CC=C1 APEJMQOBVMLION-VOTSOKGWSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9902592 | 1999-07-29 | ||
| HU9902590A HUP9902590A3 (en) | 1999-07-29 | 1999-07-29 | 3,4-dihydro isoquinolinium derivatives, pharmaceutical compositions containing them and process for producing them |
| HU9902591A HUP9902591A3 (en) | 1999-07-29 | 1999-07-29 | 3,4-dihydro isoquinolinium derivatives, pharmaceutical compositions containing such active ingredients and process for producing them |
| HU9902591 | 1999-07-29 | ||
| HU9902592A HUP9902592A3 (en) | 1999-07-29 | 1999-07-29 | Isoquinoline derivatives, pharmaceutical compositions containing such active ingredients and process for producing them |
| HU9902590 | 1999-07-29 | ||
| PCT/HU2000/000087 WO2001009101A1 (en) | 1999-07-29 | 2000-07-28 | Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2003506358A true JP2003506358A (ja) | 2003-02-18 |
Family
ID=89998920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001514304A Pending JP2003506358A (ja) | 1999-07-29 | 2000-07-28 | イソキノリン誘導体、該誘導体を含有する医薬組成物及び活性物質の製法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1200410A1 (de) |
| JP (1) | JP2003506358A (de) |
| AU (1) | AU6308900A (de) |
| CZ (1) | CZ2002342A3 (de) |
| PL (1) | PL352041A1 (de) |
| SK (1) | SK1212002A3 (de) |
| WO (1) | WO2001009101A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03000966A (es) * | 2002-02-28 | 2003-09-04 | Pfizer Prod Inc | Agentes antidiabeticos. |
| AU2010264422B2 (en) | 2009-06-26 | 2014-12-18 | Sanofi | Novel fumarate salts of a histamine H3 receptor antagonist |
| CA3107453A1 (en) * | 2018-07-23 | 2020-01-30 | Ohio State Innovation Foundation | Derivatives of papaverine that are effective hypoxic tumor radiosensitizers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH410007A (de) * | 1961-04-21 | 1966-03-31 | Hoffmann La Roche | Verfahren zur Herstellung von tertiären Aminen |
| DE1902402A1 (de) * | 1968-05-21 | 1969-11-27 | Dresden Arzneimittel | Verfahren zur Herstellung von 1-substituierten 6.7-Dimethoxy-isochinolinen |
| DE1902559A1 (de) * | 1968-07-05 | 1970-03-26 | Dresden Arzneimittel | Verfahren zur Herstellung von 1-substituierten 3,4-Dihydro-6,7-dimethoxy-isochinolinen |
| GB1181959A (en) * | 1969-01-30 | 1970-02-18 | Dresden Arzneimittel | 6,7-Dimethoxy-3,4-Dihydroisoquinoline Derivatives |
| GB8419658D0 (en) * | 1984-08-01 | 1984-09-05 | Wellcome Found | Nitrogen containing heterocyclic compounds |
| HUT71407A (en) * | 1994-05-03 | 1995-11-28 | Egyt Gyogyszervegyeszeti Gyar | Heterocyclic compounds, pharmaceutical compositions containing them, and process for producing the active components |
| EP0787493A1 (de) * | 1996-02-03 | 1997-08-06 | F. Hoffmann-La Roche Ag | Tetrahydroisochinolin-Derivate |
-
2000
- 2000-07-28 WO PCT/HU2000/000087 patent/WO2001009101A1/en not_active Application Discontinuation
- 2000-07-28 EP EP00949830A patent/EP1200410A1/de not_active Withdrawn
- 2000-07-28 PL PL00352041A patent/PL352041A1/xx unknown
- 2000-07-28 JP JP2001514304A patent/JP2003506358A/ja active Pending
- 2000-07-28 CZ CZ2002342A patent/CZ2002342A3/cs unknown
- 2000-07-28 SK SK121-2002A patent/SK1212002A3/sk unknown
- 2000-07-28 AU AU63089/00A patent/AU6308900A/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| JPN3010000375, モリソンボイド有機化学（中） 第６版, 1994, Ｐ６４７, JP, 株式会社東京化学同人 * |
Also Published As
| Publication number | Publication date |
|---|---|
| PL352041A1 (en) | 2003-07-28 |
| EP1200410A1 (de) | 2002-05-02 |
| SK1212002A3 (en) | 2002-11-06 |
| CZ2002342A3 (cs) | 2002-06-12 |
| AU6308900A (en) | 2001-02-19 |
| WO2001009101A1 (en) | 2001-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69315920T2 (de) | Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung | |
| US4113869A (en) | Tetrahydroisoquinoline basic ethers and pharmaceutical compositions and methods employing them | |
| CA1215712A (en) | Ortho substituted dihydroxy-2(1h) quinazolinone-1- alkanoic acids | |
| JPH07316113A (ja) | 新規アリールアルキル（チオ）アミド化合物 | |
| SK93994A3 (en) | Benzocycloheptenes, benzoxepines and benzothiepines and method their producing | |
| Dean et al. | Iminium salts from. alpha.-amino acid decarbonylation. Application to the synthesis of berbines | |
| US4782058A (en) | 1,3,4,6,7,11b-Hexahydro-6-phenyl-2H-pyrazino-(2,1-a)isoquinolines, for anti-histamine or anti-depression treatment | |
| Neumeyer et al. | Aporphines. 9. Synthesis and Pharmacological Evaluation of (±) 9, 10-Dihydroxyaporphine [(±)-Isoapomorphine],(±)-,(-)-, and (±)-1, 2-Dihydroxyaporphine, and (+)-1, 2, 9, 10-Tetrahydroxyaporphine. | |
| HU185133B (en) | Process for producing 1-hydroxy-octahydro-benzo-bracket-c-bracket closed-quinolines and derivatives | |
| US20030225110A1 (en) | Tetrahydroquinoline derivatives as antithrombotic agents | |
| US3988339A (en) | Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase | |
| US20050096347A1 (en) | Beta3-Adrenoreceptor agonists, agonist compositions and methods of using | |
| Reimann et al. | A convenient synthesis of 1-benzyl-1, 2, 3, 4-tetrahydroisoquinolines by combined Strecker/Bruylants reaction | |
| US4678791A (en) | 6-phenyl-1,2-3,4,4a,5-6,10b-octahydrobenz(h)isoquinolines useful for treating depression | |
| JP2003506358A (ja) | イソキノリン誘導体、該誘導体を含有する医薬組成物及び活性物質の製法 | |
| JPH06247935A (ja) | ６，７−ジアルコキシ−３，４−ジヒドロイソキノリン−８−オール類、その製造法及び該化合物を用いた６，７−ジアルコキシ−１，２，３，４−テトラヒドロイソキノリン−８−オール類の製造法 | |
| CA1129413A (en) | Tetrahydrothiopyrano ¬2,3-b| indole derivatives | |
| CA1175428A (en) | Process for preparing imidazo /1,2-a/ quinoline derivatives | |
| DE68906519T2 (de) | Aryloxypropanolaminotetraline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Arzneimittel. | |
| FI82926C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara fenetylaminderivat. | |
| JPH08337523A (ja) | 血管新生阻害剤 | |
| US4302458A (en) | Phthalidyl-isoquinoline derivatives | |
| JPH0899881A (ja) | オキサゾロキノリノン誘導体ならびにその製造法および医薬への応用 | |
| Locher et al. | Synthesis of some N-methyl-1, 2, 3, 4-tetrahydroisoquinolines by Friedel–Crafts cyclisation using benzotriazole auxiliary | |
| WO2006069775A1 (en) | 5-ht7 receptor antagonists |